Israeli Researchers Uncover Malaria Parasites' Immune Evasion Tactics

Researchers from the Weizmann Institute of Science in Rehovot, Israel, have made a significant breakthrough in understanding how malaria parasites evade the human immune system. Their study, published in the journal *Cell Reports*, reveals that malaria parasites, specifically *Plasmodium falciparum*, utilize their own messenger RNA (mRNA) to infiltrate immune cells and disrupt immune responses. This discovery could pave the way for new therapeutic strategies against malaria, which currently affects approximately 1,000 children daily and results in 500,000 deaths annually, predominantly in sub-Saharan Africa and South America.

Times of Israel

The research team, led by Dr. Paula Abou Karam and Prof. Neta Regev-Rudzki, found that malaria parasites send vesicles containing their mRNA into human immune cells. Once inside, these mRNA molecules hijack the cell's splicing machinery, specifically targeting human proteins ACIN1 and PNN, which are crucial for activating immune responses. Instead of triggering a defensive reaction against the parasites, the manipulated messages lead immune cells to the wrong location, allowing the parasites to multiply unchecked.

Times of Israel

The study faced significant setbacks due to an Iranian missile attack in June that damaged several labs at the Weizmann Institute. Despite this, the research team remained committed to their work. Regev-Rudzki emphasized the importance of continuing their research in the face of adversity, stating, “We have to stick to the science. We keep saying that in science, there are no boundaries.”

Times of Israel

Amy Buck, a professor at the University of Edinburgh, commented on the implications of the study, noting its potential relevance to other diseases beyond malaria. She stated, “It is exciting not only because it offers new insights into how malaria can evade host immunity, but also expands the context for how and where imported RNAs can function.”

Times of Israel

Regev-Rudzki expressed a personal commitment to combating malaria, stating, “For me, I feel like it’s a mission.” The team’s findings highlight the urgent need for effective malaria treatments, especially in light of the parasites' growing resistance to existing antimalarial drugs.

Times of Israel

While the study presents promising avenues for future research, the lack of an effective malaria vaccine remains a critical concern. The scientific community continues to grapple with the challenges posed by the disease, emphasizing the need for innovative solutions.

Times of Israel

• “Nobody detected this low level of the parasite’s messenger RNA (mRNA) in the nucleus of immune cells using a microscope before,” — Prof. Neta Regev-Rudzki, Weizmann Institute of Science

Times of Israel

• “This parasite is sort of a genius, because it’s only one cell,” — Prof. Neta Regev-Rudzki, Weizmann Institute of Science

Times of Israel

• “We have to somehow find the way to block this disease and all this suffering,” — Prof. Neta Regev-Rudzki, Weizmann Institute of Science

Times of Israel

• “All we knew was that we had to continue, because otherwise, they won,” — Prof. Neta Regev-Rudzki, Weizmann Institute of Science

Times of Israel

This research not only sheds light on the complex interactions between malaria parasites and the human immune system but also underscores the resilience of scientists in the face of challenges, reaffirming the critical role of scientific inquiry in addressing global health crises.

Times of Israel